Drug Trial Radar · NCT05485155
Zemaira Eosinophilic Esophagitis Pilot Study
Last checked: Nov 20, 2026Latest source record: Dec 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
May 15, 2025
Primary completion
Oct 2026
Study completion Jan 2027
Sponsor
- Lead sponsor
- Children's Hospital Medical Center, CincinnatiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- CSL Behring; National Institutes of Health (NIH)
- First posted
- Aug 3, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, open-label drug study that will examine the effects of Zemaira (alpha-1 trypsin inhibitor) in patients with Eosinophilic Esophagitis.
Conditions
- Eosinophilic Esophagitis
Interventions
Alpha-proteinase inhibitorDrug
Intravenous infusion at 120 mg/kg body weight dose/week for 4 weeks for a total of 4 infusions.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in esophageal alpha1 anti-trypsin (A1AT) concentrationTime frame: 4 weeks
- Adverse eventsTime frame: 20 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
The National Institutes of Health
Bethesda, Maryland · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.